Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins
about
Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complementInteraction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on bindingInitiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteinsRegulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membraneAnalysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsInhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranesInfectious diseases associated with complement deficiencies.Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Murine protein H is comprised of 20 repeating units, 61 amino acids in length.Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.Methylprednisolone inhibits the alternative and amplification pathways of complement.Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bThe role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusSteroids inhibit activation of the alternative-amplification pathway of complement.Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.Antibody-independent activation of the alternative complement pathway by measles virus-infected cellsRestoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.Alternative complement pathway activation increases mortality in a model of burn injury in miceComplement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.Activation of the alternative pathway of human complement by haemoglobin.In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.The regulation of complement activity by pharmacologic agents.Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.Physiology and pathophysiology of complement: progress and trends.Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuriaCell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.Function of the factor I modules (FIMS) of human complement component C6.Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.Purification of the human complement control protein C3b inactivator.Solubilization of immune precipitates by six isolated alternative pathway proteins.Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.Clinical applications of immunofixation: detection and quantitation of complement activation.A natural model of immunologic tolerance. Tolerance to murine C5 is mediated by T cells, and antigen is required to maintain unresponsiveness.Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?
P2860
Q24529520-49A07673-F4E7-4EA4-87D5-1481B8D34B45Q24684253-F684CC49-24F7-4903-8FDB-2506D5FA0C74Q28610965-AB84C9B6-4EFB-46CE-BADD-96C80B8DF2E9Q28610966-076CF314-2C5A-4108-B13A-C7BE0206C9ADQ28610971-ACE7F072-4177-4394-91D9-D4D89E7C3E73Q28610983-0032BBDC-4F63-4CA9-B914-C6F910633D58Q30450183-11F041F6-15B3-4049-90BD-DFAB5459C114Q33848520-950B4152-6490-44C0-A166-CB6ABB5F0879Q35609033-3F65F031-4FA6-415D-848E-D5C1A132122AQ36300934-DAEB9A9A-239F-43B6-BFFE-FD63396466C4Q36335057-FEEC6ADF-DECD-4613-8CE3-BAA2B2EA3BA6Q36340709-5CC9F791-4CE8-4272-AC65-9728651AE84BQ36343010-09F7E8D6-1BA2-45DF-9B96-69DD9BD0ABEEQ36343590-984F188E-00E8-48C2-A8EC-0E44C4AD2A61Q36348295-182AE535-E186-4869-9B4C-D0CE174B2F4BQ36350126-583C3D4D-0C30-4EAC-A29D-8FA327003B23Q36352460-CDD9E09C-F11B-4D74-850B-97E428A46396Q36353461-D4314A94-3A7E-4366-B77A-4BE14D07CEE2Q36426487-762C52EE-0B17-4106-B251-FE51D0EC4A4BQ36988329-7E59851A-651A-4FF7-81C5-B632D6905ACDQ37586846-0BFC935F-11F2-4797-A996-EEB8147EF155Q37596659-D371BBCA-8689-42EA-81FE-CF6A551C8FE0Q38596477-A6140365-C179-47CD-98BD-92D1F603C539Q39676453-7CD00F29-BB96-427C-A249-02C460C68607Q39677236-86FFB260-D666-407C-9819-E251A583953BQ40123049-301ABDD3-19C5-4842-A52A-7A1586C6C729Q40269086-BDBB8A34-1121-43F1-BCF0-6939087BCB99Q40380370-92B4EBCD-9C9A-4CDC-B345-420264EC014CQ40684721-FED8C536-4CD2-40C9-80CD-BF613918C419Q41112416-D1487906-22C9-4451-98D0-4DA2BB6B0DFCQ41690090-942B4ECD-5A53-4DDE-90B1-15CD8DC8D276Q41699451-91282BE4-7FBD-4D9B-89C7-974DCDA6F84EQ41821311-29A5AAF3-9F67-4F6C-8F3A-C1D84F27FE98Q41962972-C2ED49A9-8936-4784-BA88-F92CD6710151Q41967087-70FC21AE-9413-4082-AB2F-D9325EC5FB68Q41981035-9A591AF8-A8B6-4647-AF83-83464CD649A0Q42740292-08D7DFE3-732D-4806-ABAA-2B8F655458C8Q42936255-1FC4D13C-9791-4E76-B417-61A42466103EQ42936452-BDD131DB-A907-467E-B693-3870F27F625EQ49721910-47C8DABC-8BEA-41C7-A6D9-7E8896770813
P2860
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Activation of the alternative ...... of endogenous control proteins
@ast
Activation of the alternative ...... of endogenous control proteins
@en
type
label
Activation of the alternative ...... of endogenous control proteins
@ast
Activation of the alternative ...... of endogenous control proteins
@en
prefLabel
Activation of the alternative ...... of endogenous control proteins
@ast
Activation of the alternative ...... of endogenous control proteins
@en
P2860
P356
P1476
Activation of the alternative ...... of endogenous control proteins
@en
P2093
P2860
P356
10.1084/JEM.146.1.22
P407
P577
1977-07-01T00:00:00Z